Reman, Wenefredo C.

HRN: 13-12-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFTRIAXONE 1G (VIAL)
12/26/2022
01/01/2023
IV
2g
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
12/26/2022
AZITHROMYCIN 500MG TABLET (TAB)
12/26/2022
12/30/2022
ORAL
500 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: